New imaging technique may forecast lymphoma treatment response

This study explores whether advanced PET/CT scans using special tracers can predict how well patients with aggressive lymphoma will respond to treatment and their long-term outlook. Researchers will inject two types of imaging agents—FAPI and Grazytracer—to visualize the tumor's environment, including cancer-associated fibroblasts and immune cell activity. The goal is to develop models that help doctors identify patients at risk of relapse or resistance early on.